Opioid Craving clinical trials

Explore recruiting opioid craving clinical trials.

Recruiting opioid craving studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Opioid Craving trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Oral rifaximin in patients with opioid use disorder (OUD): multicenter clinical trial on the microbiota–gut–brain axis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Opioid Craving trials by city

Opioid Craving in Toronto Opioid Craving in Vancouver Opioid Craving in Montreal Opioid Craving in Calgary Opioid Craving in Edmonton Opioid Craving in Ottawa Opioid Craving in Winnipeg Opioid Craving in Quebec City Opioid Craving in Hamilton Opioid Craving in Kitchener Opioid Craving in London Opioid Craving in Halifax Opioid Craving in New York Opioid Craving in Los Angeles Opioid Craving in Chicago Opioid Craving in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease